Personalized GLP-1 Therapy and Genetic Insights While GLP-1 has been around for 30 years, personalization is new
GLP-1 Receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
GLP-1 Vitall+ Complex Innovative formula specifically for GLP-1: Patented composition: Metabolaid: Lemon Verbena + Hibiscus (clinically proven for GLP-1) Cocoa bean extract: Appetite-regulating polyphenols Berberis extract (natural berberine) Chromium: Blood sugar regulation Synergistic action: Stimulates GLP-1 + regulates appetite + balances blood sugar Dosage: As recommended by the manufacturer (generally 2 capsules/day before meals) Ideal for: People seeking targeted GLP-1 support as a complement to a healthy lifestyle Complete Protocol: Your 30-Day Action Plan Week 1: Food Foundations Food : Add 10g of fiber per day (oats, chia seeds) 25-30g of protein per meal Food order: vegetables protein carbohydrates Eliminate refined sugars Expected results: Reduced cravings, improved satiety Week 2: Consumption Habits Add: Eat slowly (20 min minimum/meal) Chew 20-30 times Hearty breakfast (before 9am) Light dinner (before 8pm) Expected results: Less food consumed, improved digestion Week 3: Lifestyle Integrate: Exercise 30 min/day (brisk walking minimum) Regular 7-8 hour sleep Heart coherence 5 min 3/day Hydration 1.5-2L/day Expected results: Stable energy, improved mood Week 4: Supplement Optimization If needed: Probiotics 10 billion CFU/day Omega-3 1000 mg/day GLP-1 Vit'all+ Complex (if weight loss is the goal) Berberine 500 mg 2/day (if insulin resistance) Expected results: Weight loss of 1-2 kg, waist circumference reduction of 2-3 cm After 30 days: stabilization Maintain : 80% of the dietary protocol Regular exercise Priority sleep Supplements: 3 months on / 1 month off Results after 3 months: Weight loss of 4-8 kg, stabilized blood sugar, naturally regulated appetite FAQ: Your questions about natural GLP-1 Is natural GLP-1 as effective as medications (Ozempic, Wegovy)
Liraglutide treatment also improved fatty liver in SKO mice, with reduced hepatomegaly, steatosis, markers of fibrosis and evidence of acute improvements of gluconeogenesis regulation in the PTT assays
It is critical to note that tirzepatide should be discontinued before attempting conception and during pregnancy
